At Psyomics, we’re helping people get the mental health support they need, sooner.



Led by CEO Dr Melinda Rees, Psyomics aims to revolutionise the way we assess, diagnose, triage, and treat mental health.



Cambridge University Biotech spinout turned Healthtech, Psyomics was founded by Professor Sabine Bahn, Laboratory Director at the Cambridge Centre for Neuropsychiatric Research.



Following more than six years of research and development, the Psyomics Platform significantly reduces clinical triage and assessment time through dynamic patient-reported information capture. Launching in late 2022 for the assessment and triage of 15+ mental health conditions, used by more than 8,500 patients to date.